Multi-copy CpG ODN-containing Plasmid Enhancing Immune Responses to HBsAg

XIE Bing,TANG Zi-wei,LAO Wen-guang,LI Jian-jun,WANG Yan,ZHU Shi-ying,TAO Qing-yuan,QI Zhong-tian,ZHAO Ping,CHEN Zhi-hui
DOI: https://doi.org/10.3724/sp.j.1008.2012.00145
2012-01-01
Abstract:Objective To explore the possibility of using plasmid containing muti-copy of CpG ODN as the adjuvant for therapeutic vaccine against hepatitis B.Methods A plasmid pKO-CG6 containing six copies of D type CpG ODN was constructed.The plasmid and the carrier plasmid pKO were used to stimulate peripheral blood monouclear cells(PBMC) of healthy or HBV infected subjects;then the proliferation of PBMCs and secretion of IFN-γ and IL-12 were examined.Recombinant HBsAg combined with either of the plasmid was used to immunize BALB/c mice,and immune responses to HBsAg were assayed.Results Both plasmid pKO-CG6 and carrier plasmid pKO not only effectively activated the proliferation response of PBMCs from healthy controls and HBV infected subjects in vitro,but also promoted the production of IFN-γ and IL-12;the immuno-stimulation activity of pKO-CG6 was greatly stronger than that of the carrier plasmid pKO.In vivo study showed that although vector pKO could also act as immunological adjuvant for HBsAg in mice,plasmid pKO-CG6 elicited much stronger immune responses to HBsAg,especially the cell-mediated response.Conclusion Plasmid containing multi-copy of CpG ODN can effectively activate PBMCs of HBV infected subjects and enhance the immune responses to HBsAg in mice.
What problem does this paper attempt to address?